News | January 23, 2013

St. Jude Medical Announces CE Mark Approval of ViewFlex Xtra ICE Catheter

New catheter provides real-time, high-resolution ultrasound images of blood flow and cardiac anatomy when paired with the ViewMate Z Intracardiac Ultrasound Console

ViewFlex Xtra ICE Catheter St. Jude Medical CE mark

January 23, 2013 — St. Jude Medical Inc. announced European CE mark approval of its ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Designed for control and maneuverability during complex cardiac ablation procedures, the technology will be on display at the eighteenth annual Boston AF Symposium.

Offering a four-way directional tip, the ViewFlex Xtra ICE Catheter also has the added benefit of auto-lock steering, which allows for single-handed operation of the catheter to minimize repositioning. Paired with the ViewMate Z Intracardiac Ultrasound Console, the integrated products help clinicians better visualize, in real-time, a patient’s cardiac anatomy, including internal structure of the heart and blood flow direction. The high-resolution images and vivid color displays provide improved guidance for physicians.

“This technology offers crisp, clear visualization of the patient’s anatomy to help guide us in performing a variety of procedures such as radiofrequency ablation to treat irregular heart rhythms,” said Dhanunjaya Lakkireddy, M.D., cardiologist and professor of internal medicine at the University of Kansas Hospital in Kansas City, Kan. “The ViewFlex ICE Catheter’s easy to use, one-handed operation allows for a more efficient procedure.”

The catheter is inserted in the body through a small incision in the femoral vein (located in the leg) and guided to the heart. Featuring an ergonomic handle, the ViewFlex Xtra ICE Catheter offers improved maneuverability to enhance procedural workflow.

“The combination of the ViewFlex Xtra ICE Catheter and ViewMate Z Intracardiac Ultrasound Console in an integrated EP lab not only yields exceptional images, but more importantly allows physicians to focus on the patient and less on catheter manipulation,” said Frank J. Callaghan, president of the Cardiovascular and Ablation Technologies Division at St. Jude Medical.

The ViewFlex Xtra ICE Catheter received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in 2012.

For more information: sjm.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
GE’s blood speckle imaging (BSI) software shows the flow of blood cells’ trajectories. It is a form of blood vector flow imaging.

GE’s blood speckle imaging (BSI) software offers the ability to view a graphical representation of the blood cells’ trajectories.

News | Cardiovascular Ultrasound| September 01, 2017
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advance
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init